Compare RLMD & CSV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLMD | CSV |
|---|---|---|
| Founded | 2004 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 752.1M | 686.0M |
| IPO Year | 2012 | 1996 |
| Metric | RLMD | CSV |
|---|---|---|
| Price | $6.93 | $40.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $12.40 | ★ $59.00 |
| AVG Volume (30 Days) | ★ 869.6K | 97.3K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.92% |
| EPS Growth | 45.28 | ★ 54.76 |
| EPS | N/A | ★ 0.84 |
| Revenue | $13,070.00 | ★ $417,440,000.00 |
| Revenue This Year | N/A | $7.35 |
| Revenue Next Year | N/A | $3.87 |
| P/E Ratio | ★ N/A | $49.26 |
| Revenue Growth | ★ 154.83 | 3.28 |
| 52 Week Low | $0.52 | $39.88 |
| 52 Week High | $8.00 | $52.10 |
| Indicator | RLMD | CSV |
|---|---|---|
| Relative Strength Index (RSI) | 45.89 | 30.50 |
| Support Level | $6.81 | N/A |
| Resistance Level | $7.46 | $44.87 |
| Average True Range (ATR) | 0.42 | 1.39 |
| MACD | -0.04 | -0.31 |
| Stochastic Oscillator | 50.17 | 7.32 |
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.
Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise. The company enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.